… Especially in immunocompromised patients, coinfection of genital warts with high‐risk HPV
… Immunocompromised patients with suppressed cellular immunity (HIV‐infected persons) …

… warts and plantar warts are predominantly caused by HPV types 1 and 2, while roughly 90%
of genital warts … only three warts (43%) resolved; however, the immunocompromised state of …

Background Extragenital warts (E-GWs) are common benign skin lesions caused by human
papilloma virus. Surprisingly, there is no clear data about the impact of multiple E-GWs on …

… Genital warts (condyloma acuminatum, venereal warts) are common highly contagious …
for warts resistant to treatment and for verrucous lesions in immunocompromised individuals. …

… , if they had been treated for genital warts within a month of study entry, or if history and
physical examination indicated that they might have been immunocompromised. The study was …

… genital warts have shown a much higher HPV prevalence in HIV‐seropositive than seronegative
individuals… the HPV present in HIV‐seropositive individuals which could have prevented …

… the immunocompromised population, in which extensive warts are often a problem. The
efficacy of imiquimod represents a positive indication of the importance of the immune system in …

Rising rates of human papillomavirus (HPV) infections in recent decades, including external
genital warts (EGWs), underscore the need for effective management of this common …

… of genital warts is very frequently seen in the puerperium. Treatment in immunocompromised
… outcome of treatment for genital warts, there is a clear individual and public health rationale …

… GENITAL WARTS IS A highly infectious sexually transmitted disease … genital warts 4 with
the highest prevalence observed among women of 20–24 years of age. Benign genital warts …